Healthcare -
Biotechnology - NASDAQ - DE
$ 4.1
-1.91 %
$ 920 M
Market Cap
8.54
P/E
CVAC - STOCK-BASED COMPENSATION
Stock-based Compensation CVAC - CureVac N.V.
7.7 M
LAST VALUE
-28.26%
2 YEAR CAGR
30.69%
5 YEAR CAGR
0.00%
10 YEAR CAGR